Tempus AI (TEM) stock jumped 24% after Merck-Moderna's cancer vaccine Phase 3 success validated its $1.5B Personalis acquisition and boosted investor sentiment. The post Tempus AI (TEM) Stock Rockets 24% Following Merck-Moderna Cancer Vaccine Breakthrough appeared first on Blocko...